US equities |
MU $940.26 ▼-1.36% NVDA $223.99 ▼-1.98% AAPL $345.30 ▲+1.18% SPCX $153.81 ▼-1.74% META $745.65 ▼-2.21% TSLA $368.15 ▼-1.89% SNDK $1,437.81 ▼-3.00% AMD $584.95 ▼-3.40%
FinancialContent

Latest News about Anthony P/ Mack

Recent news which mentions Anthony P/ Mack

Virpax Receives pre-IND Application Guidance From The FDA For Its CBD-Based Drug Candidate For Epilepsy
Tickers VRPX
Tags Nanomerics VRPX Penny Stocks
From Benzinga
Lab Notes: FMC enters into a $200M bio-acquisition; Virpax going the OTC route again
Tickers INNO
Tags Virpax Pharmaceuticals Inc/ Inno Maria L/ Maccecchini
From Business Journals
Lab Notes: Helius launches flagship product in U.S.; Virpax reports positive preclinical results for seizure drug
Tickers INNO
Tags Andreas G/ Schätzlein Pharmaceuticals Jeffrey Dayno
From Business Journals
Virpax shares rise on expanded licensing deal for experimental drug
Tags Anthony P/ Mack Health Care Insurance
From Business Journals
Lab Notes: LIMR awarded research grant; Virpax posts positive study results for pain treatment
Tickers INNO
Tags Health Care Elizabeth Tarka Strata Skin Sciences Inc/
From Business Journals
Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more
Tickers INNO
Tags Steven Kelly Virpax Pharmaceuticals Inc/ Inno
From Business Journals